Dr. Tessa L Holyoake - CML - Chronic Myeloid Leukemia
Professor of Experimental Haematology
Paul O'Gorman Leukaemia Research Centre,
Section of Experimental Haematology,
Faculty of Medicine,
University of Glasgow
Extract of Univ. Of Glasgow - Heamatology
Paul O'Gorman Leukaemia Research Centre,
Section of Experimental Haematology,
Faculty of Medicine,
University of Glasgow
Extract of Univ. Of Glasgow - Heamatology
VIDEOS
University of Glasgow scientists successfully target leukaemia cells
June 10, 2016, University of Glasgow
Professor Tessa Holyoake on stem cell research
April 24, 2014, Children with Cancer UK
ARTICLES
Professor Tessa Holyoake, hailed as one of the most exceptional scientists of her generation, lost her battle with breast cancer last week
September 7, 2017, GlasgowLive
Presentation of the RSE Royal Medals by Her Majesty the Queen 2017
August 14, 2017, Royal Society Edinburgh
The 2017 Rowley Prize is awarded to Professor Tessa Holyoake
2017, iCMLf
A trial looking at different ways of giving imatinib to people with CML (GIMI)
November 20, 2015, Cancer Research UK
Award for Glasgow cancer specialist
November 16, 2015, BBC News
A trial of hydroxychloroquine with imatinib for chronic myeloid leukaemia (CHOICES)
January 15, 2015, Cancer Research UK
The anti-proliferative activity of kinase inhibitors in chronic myeloid leukaemia cells is mediated by FOXO transcription factors
2014, Stem Cells
p53 and c-Myc Are Critical Signaling Hubs That Maintain Chronic Myeloid Leukemia
November 15, 2013, Journal Blood
Fellowship honour for Professor Tessa Holyoake
May 9, 2013, University of Glasgow
A study looking at how nilotinib affects CYP enzymes in chronic myeloid leukaemia
March 1, 2013, Cancer Research UK
Glasgow Professor discusses about new approach for CML treatment at UK conference
March 31, 2011, News Medical
New approach to leukemia chemotherapy -- is a cure in sight?
March 30, 2011, ScienceDaily
Hydroxychloroquine for chronic myeloid leukemia: complete cure on the horizon?
2011, University of Glasgow
Recent advances in the molecular and cellular biology of chronic myeloid leukaemia: lessons to be learned from the laboratory
January 12, 2002, British Journal of haematology
University of Glasgow scientists successfully target leukaemia cells
June 10, 2016, University of Glasgow
Professor Tessa Holyoake on stem cell research
April 24, 2014, Children with Cancer UK
ARTICLES
Professor Tessa Holyoake, hailed as one of the most exceptional scientists of her generation, lost her battle with breast cancer last week
September 7, 2017, GlasgowLive
Presentation of the RSE Royal Medals by Her Majesty the Queen 2017
August 14, 2017, Royal Society Edinburgh
The 2017 Rowley Prize is awarded to Professor Tessa Holyoake
2017, iCMLf
A trial looking at different ways of giving imatinib to people with CML (GIMI)
November 20, 2015, Cancer Research UK
Award for Glasgow cancer specialist
November 16, 2015, BBC News
A trial of hydroxychloroquine with imatinib for chronic myeloid leukaemia (CHOICES)
January 15, 2015, Cancer Research UK
The anti-proliferative activity of kinase inhibitors in chronic myeloid leukaemia cells is mediated by FOXO transcription factors
2014, Stem Cells
p53 and c-Myc Are Critical Signaling Hubs That Maintain Chronic Myeloid Leukemia
November 15, 2013, Journal Blood
Fellowship honour for Professor Tessa Holyoake
May 9, 2013, University of Glasgow
A study looking at how nilotinib affects CYP enzymes in chronic myeloid leukaemia
March 1, 2013, Cancer Research UK
Glasgow Professor discusses about new approach for CML treatment at UK conference
March 31, 2011, News Medical
New approach to leukemia chemotherapy -- is a cure in sight?
March 30, 2011, ScienceDaily
Hydroxychloroquine for chronic myeloid leukemia: complete cure on the horizon?
2011, University of Glasgow
Recent advances in the molecular and cellular biology of chronic myeloid leukaemia: lessons to be learned from the laboratory
January 12, 2002, British Journal of haematology
